Product manufacturers and distributors at some of the
world’s largest buyside firms have explained to
Practice Insight just how much chaos the new Priips regime is
causing. The market is now collating the various issues
surrounding the controversial new regulation which could expose
firms to bad PR at best, and litigation at worse. Read the full story now.
And banks, stock exchanges, industry associations and even
some MEPs are uniting against the controversial Omnibus III
proposal that suggests shifting prospectus approval from
national competent authorities to the European Securities and
Markets Authority. The full story is here.
Practice Insight is a new weekly service from IFLR,
uncovering regulatory-driven uncertainty within banks, asset
managers and trading venues. To sign up for the free weekly
newsletter click here,
and to follow us on Twitter click here.